Literature DB >> 20868464

Neurophysiological tests and neuroimaging procedures in non-acute headache (2nd edition).

G Sandrini1, L Friberg, G Coppola, W Jänig, R Jensen, M Kruit, P Rossi, D Russell, M Sanchez del Rìo, T Sand, J Schoenen.   

Abstract

BACKGROUND AND
PURPOSE: A large number of instrumental investigations are used in patients with non-acute headache in both research and clinical fields. Although the literature has shown that most of these tools contributed greatly to increasing understanding of the pathogenesis of primary headache, they are of little or no value in the clinical setting.
METHODS: This paper provides an update of the 2004 EFNS guidelines and recommendations for the use of neurophysiological tools and neuroimaging procedures in non-acute headache (first edition). Even though the period since the publication of the first edition has seen an increase in the number of published papers dealing with this topic, the updated guidelines contain only minimal changes in the levels of evidence and grades of recommendation.
RESULTS: (i) Interictal EEG is not routinely indicated in the diagnostic evaluation of patients with headache. Interictal EEG is, however, indicated if the clinical history suggests a possible diagnosis of epilepsy (differential diagnosis). Ictal EEG could be useful in certain patients suffering from hemiplegic or basilar migraine. (ii) Recording evoked potentials is not recommended for the diagnosis of headache disorders. (iii) There is no evidence warranting recommendation of reflex responses or autonomic tests for the routine clinical examination of patients with headache. (iv) Manual palpation of pericranial muscles, with standardized palpation pressure, can be recommended for subdividing patient groups but not for diagnosis. Pain threshold measurements and EMG are not recommended as clinical diagnostic tests. (v) In adult and pediatric patients with migraine, with no recent change in attack pattern, no history of seizures, and no other focal neurological symptoms or signs, the routine use of neuroimaging is not warranted. In patients with trigeminal autonomic cephalalgia, neuroimaging should be carefully considered and may necessitate additional scanning of intracranial/cervical vasculature and/or the sellar/orbital/(para)nasal region. In patients with atypical headache patterns, a history of seizures and/or focal neurological symptoms or signs, MRI may be indicated. (vi) If attacks can be fully accounted for by the standard headache classification (IHS), a PET or SPECT scan will normally be of no further diagnostic value. Nuclear medical examinations of the cerebral circulation and metabolism can be carried out in subgroups of patients with headache for the diagnosis and evaluation of complications, when patients experience unusually severe attacks or when the quality or severity of attacks has changed. (vii) Transcranial Doppler examination is not helpful in headache diagnosis.
CONCLUSION: Although many of the examinations described in the present guidelines are of little or no value in the clinical setting, most of the tools, including thermal pain thresholds and transcranial magnetic stimulation, have considerable potential for differential diagnostic evaluation as well as for the further exploration of headache pathophysiology and the effects of pharmacological treatment.
© 2010 The Author(s). European Journal of Neurology © 2010 EFNS.

Entities:  

Mesh:

Year:  2010        PMID: 20868464     DOI: 10.1111/j.1468-1331.2010.03212.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  13 in total

1.  The real usefulness and indication for migraine diagnosis of neurophysiologic evaluation.

Authors:  G Viticchi; L Falsetti; M Silvestrini; S Luzzi; L Provinciali; M Bartolini
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

2.  How neurologists can choose (even more) wisely: prioritizing waste reduction targets and identifying gaps in knowledge.

Authors:  Brian C Callaghan; James F Burke; Eva L Feldman
Journal:  JAMA       Date:  2014 Apr 23-30       Impact factor: 56.272

3.  Headaches and neuroimaging: high utilization and costs despite guidelines.

Authors:  Brian C Callaghan; Kevin A Kerber; Robert J Pace; Lesli E Skolarus; James F Burke
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

Review 4.  [Headache in the emergency department].

Authors:  C J Schankin; A Straube; C L Bassetti; U Fischer
Journal:  Nervenarzt       Date:  2017-06       Impact factor: 1.214

5.  Headache neuroimaging: Routine testing when guidelines recommend against them.

Authors:  Brian C Callaghan; Kevin A Kerber; Robert J Pace; Lesli Skolarus; Wade Cooper; James F Burke
Journal:  Cephalalgia       Date:  2015-02-12       Impact factor: 6.292

6.  Neuroimaging overuse is more common in Medicare compared with the VA.

Authors:  James F Burke; Eve A Kerr; Ryan J McCammon; Rob Holleman; Kenneth M Langa; Brian C Callaghan
Journal:  Neurology       Date:  2016-07-08       Impact factor: 9.910

7.  Headache neuroimaging: A survey of current practice, barriers, and facilitators to optimal use.

Authors:  Evan L Reynolds; James F Burke; Lacey Evans; Faiz I Syed; Eric Liao; Remy Lobo; Wade Cooper; Larry Charleston; Brian C Callaghan
Journal:  Headache       Date:  2022-01       Impact factor: 5.311

Review 8.  Is there a persistent dysfunction of neurovascular coupling in migraine?

Authors:  Andrej Fabjan; Marjan Zaletel; Bojana Žvan
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

9.  European Headache Federation consensus on technical investigation for primary headache disorders.

Authors:  D D Mitsikostas; M Ashina; A Craven; H C Diener; P J Goadsby; M D Ferrari; C Lampl; K Paemeleire; J Pascual; A Siva; J Olesen; V Osipova; P Martelletti
Journal:  J Headache Pain       Date:  2016-02-09       Impact factor: 7.277

10.  Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study.

Authors:  Ninett Louise Find; Rossana Terlizzi; Signe Bruun Munksgaard; Lars Bendtsen; Cristina Tassorelli; Giuseppe Nappi; Zaza Katsarava; Miguel Lainez; Maria Teresa Goicochea; Beatriz Shand; Ricardo Fadic; Santiago Spadafora; Marco Pagani; Rigmor Jensen
Journal:  J Headache Pain       Date:  2016-03-08       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.